Allergan Investors' Attys Claim $30.9M Of Price-Fixing Deal
The attorneys who secured a $130 million settlement for Allergan investors who sued the pharmaceutical company over allegations that it participated in a generic drug price-fixing scheme will walk away with...To view the full article, register now.
Already a subscriber? Click here to view full article